For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your country/region into the box below, to view site information related to your country/region.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Access advice and support for any research roadblock
View support hub
Your experiments laid out step by step
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Supporting our customers and employees during the COVID-19 pandemic. Read more
Explore information and products associated with cytokine storm in novel coronavirus research.
The CR3022 antibody for the SARS-CoV-2 spike protein was used to identify the SARS-CoV-2 protein crystal structure and may have therapeutic potential for the treatment of COVID-19.
Explore the structural and functional mechanisms involved in SARS-CoV-2 cell entry.
Find out how we validate our SimpleStep ELISA kits for key COVID-19 targets to provide you with fast, reproducible results.
Understanding the antibody response to SARS-CoV-2 infection and being able to detect this via ELISA and LFA is critical to limiting the spread of COVID-19.
Consistent supplies of SARS-CoV-2 proteins have limited research. We manufacture fit-for-purpose recombinant proteins to remove these barriers.
Easily quantify cytokines, growth factors, kinases, and other key inflammation proteins with flexible, highly specific ELISAs.
SimpleStep ELISA® technology: accuracy and speed when assessing COVID-19
Establishing biomarkers for COVID-19 could help treat more rapidly and effectively
Our response to the evolving COVID-19 global situation.